Lactobacillus acidophilus CUL60
Lactobacillus acidophilus CUL60 is a component of the Lab4 multi-strain probiotic consortium, and its research record is largely tied to that combination rather than to the isolate alone. Human clinical trials involving the Lab4 consortium have examined gastrointestinal symptoms in the context of irritable bowel syndrome and marathon running, and an observational study examined the consortium in the context of respiratory health in preschool-aged children. A genomic evaluation of the Lab4 consortium characterized CUL60's genetic profile. Strain-specific human clinical evidence independent of the consortium is limited; most findings are attributable to the combined formulation rather than CUL60 alone. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 7 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 3 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
7 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.